Showing promise in the arena of excess body fat therapy, retatrutide presents a distinct method. Unlike many available medications, retatrutide works as a double agonist, simultaneously affecting both GLP-like peptide-1 (GLP-1) and glucose-responsive insulinotropic hormone (GIP) binding sites. This dual engagement promotes various beneficial effect… Read More